|
1
|
Zhang C and Liu N: Ferroptosis,
necroptosis, and pyroptosis in the occurrence and development of
ovarian cancer. Front Immunol. 13:9200592022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu Y, Lin Z, Zhao N, Zhou L, Liu F,
Cichacz Z, Zhang L, Zhan Q and Zhao X: Receptor interactive protein
kinase 3 promotes Cisplatin-triggered necrosis in
apoptosis-resistant esophageal squamous cell carcinoma cells. PLoS
One. 9:e1001272014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Su SS, Zhao S, Yang Z, Zhong CQ,
Chen X, Cai Q, Yang ZH, Huang D, Wu R and Han J: RIP1
autophosphorylation is promoted by mitochondrial ROS and is
essential for RIP3 recruitment into necrosome. Nat Commun.
8:143292017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schenk B and Fulda S: Reactive oxygen
species regulate Smac mimetic/TNFα-induced necroptotic signaling
and cell death. Oncogene. 34:5796–5806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu SK, Chang WT, Lin IL, Chen YF,
Padalwar NB, Cheng KC, Teng YN, Wang CH and Chiu CC: The role of
necroptosis in ROS-Mediated cancer therapies and its promising
applications. Cancers (Basel). 12:21852020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shindo R, Kakehashi H, Okumura K, Kumagai
Y and Nakano H: Critical contribution of oxidative stress to
TNFα-induced necroptosis downstream of RIPK1 activation. Biochem
Biophys Res Commun. 436:212–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Narang VS, Pauletti GM, Gout PW, Buckley
DJ and Buckley AR: Suppression of cystine uptake by sulfasalazine
inhibits proliferation of human mammary carcinoma cells. Anticancer
Res. 23:4571–4579. 2003.PubMed/NCBI
|
|
8
|
Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y,
Harris BK, Hoeksema MD, Trenary IA, Heidi C, Eisenberg R, et al:
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small
cell lung cancer progression. Oncogene. 37:5007–5019. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge
C, Liang L, Jia D, Chen T, Yao M, et al: Disruption of xCT inhibits
cell growth via the ROS/autophagy pathway in hepatocellular
carcinoma. Cancer Lett. 312:55–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jovanović L, Nikolić A, Dragičević S,
Jović M and Janković R: Prognostic relevance of autophagy-related
markers p62, LC3, and Beclin1 in ovarian cancer. Croat Med J.
63:453–460. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams O, Dislich B, Berezowska S, Schläfli
AM, Seiler CA, Kröll D, Tschan MP and Langer R: Prognostic
relevance of autophagy markers LC3B and p62 in esophageal
adenocarcinomas. Oncotarget. 7:39241–39255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kharaziha P, Chioureas D, Baltatzis G,
Fonseca P, Rodriguez P, Gogvadze V, Lennartsson L, Björklund AC,
Zhivotovsky B, Grandér D, et al: Sorafenib-induced defective
autophagy promotes cell death by necroptosis. Oncotarget.
6:37066–37082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goodall ML, Cramer SD and Thorburn A:
Autophagy RIPs into cell death. Cell Cycle. 15:3014–3015. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanz L, Sanchez P, Lallena MJ, Diaz-Meco
MT and Moscat J: The interaction of p62 with RIP links the atypical
PKCs to NF-kappaB activation. EMBO J. 18:3044–3053. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan XY, Zhong XR, Yu SH, Zhang LC, Liu YN,
Zhang Y, Sun LK and Su J: p62 aggregates mediated Caspase 8
activation is responsible for progression of ovarian cancer. J Cell
Mol Med. 23:4030–4042. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaiser WJ, Daley-Bauer LP, Thapa RJ,
Mandal P, Berger SB, Huang C, Sundararajan A, Guo H, Roback L,
Speck SH, et al: RIP1 suppresses innate immune necrotic as well as
apoptotic cell death during mammalian parturition. Proc Natl Acad
Sci USA. 111:7753–7758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galluzzi L, Vitale I, Aaronson SA, Abrams
JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews
DW, et al: Molecular mechanisms of cell death: Recommendations of
the Nomenclature Committee on cell death 2018. Cell Death Differ.
25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu H, Su J, Xu Y, Kang J, Li H, Zhang L,
Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin
resistance in human ovarian cancer cells by clearing ubiquitinated
proteins. Eur J Cancer. 47:1585–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goodall ML, Fitzwalter BE, Zahedi S, Wu M,
Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD and
Thorburn A: The Autophagy Machinery controls cell death switching
between apoptosis and necroptosis. Dev Cell. 37:337–349. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen D, Yu J and Zhang L: Necroptosis: An
alternative cell death program defending against cancer. Biochim
Biophys Acta. 1865:228–236. 2016.PubMed/NCBI
|
|
21
|
Basit F, Cristofanon S and Fulda S:
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly
of the necrosome on autophagosomal membranes. Cell Death Differ.
20:1161–1173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dolapçi İB, Noyan S, Polat AY, Gürdal H
and Dedeoğlu BG: miR-216b-5p promotes late apoptosis/necroptosis in
trastuzumab-resistant SK-BR-3 cells. Turk J Biol. 47:199–207. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bagherpoor AJ, Shameem M, Luo X, Seelig D
and Kassie F: Inhibition of lung adenocarcinoma by combinations of
sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line
models and mice. Carcinogenesis. 44:291–303. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su J, Liu F, Xia M, Xu Y, Li X, Kang J, Li
Y and Sun L: p62 participates in the inhibition of NF-κB signaling
and apoptosis induced by sulfasalazine in human glioma U251 cells.
Oncol Rep. 34:235–243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bray K, Mathew R, Lau A, Kamphorst JJ, Fan
J, Chen J, Chen HY, Ghavami A, Stein M, DiPaola RS, et al:
Autophagy suppresses RIP kinase-dependent necrosis enabling
survival to mTOR inhibition. PLoS One. 7:e418312012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Kobayashi M, Blonska M, You Y and
Lin X: Ubiquitination of RIP is required for tumor necrosis factor
alpha-induced NF-kappaB activation. J Biol Chem. 281:13636–13643.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tenev T, Bianchi K, Darding M, Broemer M,
Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K
and Meier P: The Ripoptosome, a signaling platform that assembles
in response to genotoxic stress and loss of IAPs. Mol Cell.
43:432–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Holler N, Zaru R, Micheau O, Thome M,
Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp
J: Fas triggers an alternative, caspase-8-independent cell death
pathway using the kinase RIP as effector molecule. Nat Immunol.
1:489–495. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu S, Yan X, Tian R, Xu L, Zhao Y, Sun L
and Su J: An experimentally induced mutation in the UBA Domain of
p62 changes the sensitivity of cisplatin by Up-Regulating HK2
localisation on the mitochondria and increasing mitophagy in A2780
ovarian cancer cells. Int J Mol Sci. 22:39832021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang YY, Zhang J, Liu XM, Li Y, Sui J,
Dong MQ, Ye K and Du LL: Molecular and structural mechanisms of ZZ
domain-mediated cargo selection by Nbr1. EMBO J. 40:e1074972021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan XY, Zhang Y, Zhang JJ, Zhang LC, Liu
YN, Wu Y, Xue YN, Lu SY, Su J and Sun LK: p62/SQSTM1 as an
oncotarget mediates cisplatin resistance through activating
RIP1-NF-κB pathway in human ovarian cancer cells. Cancer Sci.
108:1405–1413. 2017. View Article : Google Scholar : PubMed/NCBI
|
